{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:06:20Z","timestamp":1789477580782,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Hangzhou Health Science and Technology Projects","award":["A20220558"],"award-info":[{"award-number":["A20220558"]}]},{"name":"the Hangzhou Health Science and Technology Projects","award":["A20220558"],"award-info":[{"award-number":["A20220558"]}]},{"name":"the Hangzhou Health Science and Technology Projects","award":["A20220558"],"award-info":[{"award-number":["A20220558"]}]},{"name":"the Hangzhou Health Science and Technology Projects","award":["A20220558"],"award-info":[{"award-number":["A20220558"]}]},{"name":"the Hangzhou Health Science and Technology Projects","award":["A20220558"],"award-info":[{"award-number":["A20220558"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-022-00900-6","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T13:04:39Z","timestamp":1664283879000},"page":"1307-1316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High plasma EBV-DNA load and positive EBER status associated with viral recurrence and persistent infection in early treatment of lymphoma"],"prefix":"10.1007","volume":"23","author":[{"given":"Meichun","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"issue":"20","key":"900_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"issue":"18","key":"900_CR2","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1182\/blood.2020008157","volume":"136","author":"N Abe","year":"2020","unstructured":"Abe N, Fujieda Y. Chronic active Epstein-Barr virus infection. Blood. 2020;136(18):2090.","journal-title":"Blood"},{"key":"900_CR3","doi-asserted-by":"publisher","first-page":"629780","DOI":"10.3389\/fonc.2021.629780","volume":"11","author":"MML Leong","year":"2021","unstructured":"Leong MML, Lung ML. The impact of Epstein-Barr virus infection on epigenetic regulation of host cell gene expression in Epithelial and Lymphocytic Malignancies. Front Oncol. 2021;11:629780.","journal-title":"Front Oncol"},{"issue":"4","key":"900_CR4","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1093\/oncolo\/oyac024","volume":"27","author":"C Lin","year":"2022","unstructured":"Lin C, et al. Plasma Epstein-Barr virus MicroRNA BART8-3p as a diagnostic and prognostic biomarker in nasopharyngeal carcinoma. Oncologist. 2022;27(4):e340\u20139.","journal-title":"Oncologist"},{"issue":"12","key":"900_CR5","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3855\/jidc.14919","volume":"15","author":"R Habeeb","year":"2021","unstructured":"Habeeb R, Al Hafar L, Monem F. EBV plasma Epstein-Barr Virus (EBV) DNA as a biomarker for diagnosis of EBV-positive Hodgkin lymphoma in Syria. J Infect Dev Ctries. 2021;15(12):1917\u201322.","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"900_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/jmv.27440","volume":"94","author":"R Pramanik","year":"2022","unstructured":"Pramanik R, et al. Cell-free EBV DNA as a biomarker during clinical management of nasopharyngeal carcinoma in a nonendemic region. J Med Virol. 2022;94(2):720\u20138.","journal-title":"J Med Virol"},{"key":"900_CR7","doi-asserted-by":"publisher","first-page":"804083","DOI":"10.3389\/fonc.2021.804083","volume":"11","author":"RR Xian","year":"2021","unstructured":"Xian RR, et al. Plasma EBV DNA: A promising diagnostic marker for endemic Burkitt lymphoma. Front Oncol. 2021;11:804083.","journal-title":"Front Oncol"},{"issue":"2","key":"900_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/cam4.2710","volume":"9","author":"ND Montgomery","year":"2020","unstructured":"Montgomery ND, et al. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi. Cancer Med. 2020;9(2):552\u201361.","journal-title":"Cancer Med"},{"issue":"2","key":"900_CR9","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1097\/HS9.0000000000000523","volume":"5","author":"JA van Doesum","year":"2021","unstructured":"van Doesum JA, et al. Extranodal natural killer\/T-cell lymphoma, nasal type: Diagnosis and treatment. Hemasphere. 2021;5(2):e523.","journal-title":"Hemasphere"},{"issue":"3","key":"900_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s12288-019-01088-8","volume":"35","author":"T Kostadinova","year":"2019","unstructured":"Kostadinova T, et al. Detection of EBV DNA in Non-Hodgkin Lymphoma patients in Bulgaria. Indian J Hematol Blood Transfus. 2019;35(3):465\u201370.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"900_CR11","first-page":"6627620","volume":"2021","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Clinical features of intestinal Ulcers complicated by Epstein-Barr Virus infection: Importance of active infection. Dis Markers. 2021;2021:6627620.","journal-title":"Dis Markers"},{"issue":"4","key":"900_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ajh.25760","volume":"95","author":"BE Beltran","year":"2020","unstructured":"Beltran BE, et al. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(4):435\u201345.","journal-title":"Am J Hematol"},{"issue":"6","key":"900_CR13","doi-asserted-by":"publisher","first-page":"e0199398","DOI":"10.1371\/journal.pone.0199398","volume":"13","author":"X Gao","year":"2018","unstructured":"Gao X, et al. Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis. PLoS ONE. 2018;13(6):e0199398.","journal-title":"PLoS ONE"},{"issue":"9","key":"900_CR14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jmoldx.2022.06.002","volume":"24","author":"J Song","year":"2022","unstructured":"Song J, et al. Utility of Epstein-Barr Viral load in blood for diagnosis and predicting prognosis of lymphoma: A comparison with Epstein-Barr Virus-Encoded RNA in Situ Hybridization. J Mol Diagn. 2022;24(9):977\u201391.","journal-title":"J Mol Diagn"},{"issue":"2","key":"900_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/cam4.2742","volume":"9","author":"AE Eladl","year":"2020","unstructured":"Eladl AE, et al. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Cancer Med. 2020;9(2):678\u201388.","journal-title":"Cancer Med"},{"key":"900_CR16","doi-asserted-by":"publisher","first-page":"175628482093012","DOI":"10.1177\/1756284820930124","volume":"13","author":"S Xu","year":"2020","unstructured":"Xu S, et al. Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area. Therap Adv Gastroenterol. 2020;13:1756284820930124.","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"900_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hon.2245","volume":"35","author":"A Okamoto","year":"2017","unstructured":"Okamoto A, et al. The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients. Hematol Oncol. 2017;35(1):87\u201393.","journal-title":"Hematol Oncol"},{"issue":"1","key":"900_CR18","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1038\/s41598-021-82534-4","volume":"11","author":"JH Kim","year":"2021","unstructured":"Kim JH, et al. Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma. Sci Rep. 2021;11(1):2880.","journal-title":"Sci Rep"},{"issue":"2","key":"900_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ijc.33802","volume":"150","author":"Z Shen","year":"2022","unstructured":"Shen Z, et al. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group. Int J Cancer. 2022;150(2):327\u201334.","journal-title":"Int J Cancer"},{"issue":"16","key":"900_CR20","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","volume":"127","author":"JA Kanakry","year":"2016","unstructured":"Kanakry JA, et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127(16):2007\u201317.","journal-title":"Blood"},{"issue":"12","key":"900_CR21","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1097\/PAS.0000000000001809","volume":"45","author":"T Kawano","year":"2021","unstructured":"Kawano T, et al. Clinicopathologic analysis of primary adrenal diffuse large B-Cell Lymphoma: A reappraisal of 23 Japanese patients based on EBV association and PD-L1 expression in Tumor cells. Am J Surg Pathol. 2021;45(12):1606\u201315.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"900_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5045\/br.2020.55.1.49","volume":"55","author":"YJ Li","year":"2020","unstructured":"Li YJ, et al. HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases. Blood Res. 2020;55(1):49\u201356.","journal-title":"Blood Res"},{"issue":"1","key":"900_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/hon.2468","volume":"36","author":"YW Koh","year":"2018","unstructured":"Koh YW, et al. Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin\u2019s lymphoma. Hematol Oncol. 2018;36(1):182\u20138.","journal-title":"Hematol Oncol"},{"issue":"25","key":"900_CR24","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","volume":"121","author":"E Tse","year":"2013","unstructured":"Tse E, Kwong YL. How I treat NK\/T-cell lymphomas. Blood. 2013;121(25):4997\u20135005.","journal-title":"Blood"},{"issue":"45","key":"900_CR25","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1038\/onc.2009.258","volume":"28","author":"B Gruhne","year":"2009","unstructured":"Gruhne B, Sompallae R, Masucci MG. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene. 2009;28(45):3997\u20134008.","journal-title":"Oncogene"},{"issue":"12","key":"900_CR26","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1182\/blood-2016-02-702530","volume":"128","author":"YC Huang","year":"2016","unstructured":"Huang YC, et al. Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients\u2019 survival. Blood. 2016;128(12):1578\u201389.","journal-title":"Blood"},{"issue":"6","key":"900_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ebiom.2015.04.018","volume":"2","author":"A Ferrajoli","year":"2015","unstructured":"Ferrajoli A, et al. Epstein-Barr Virus MicroRNAs are expressed in patients with Chronic Lymphocytic Leukemia and correlate with overall survival. EBioMedicine. 2015;2(6):572\u201382.","journal-title":"EBioMedicine"},{"issue":"30","key":"900_CR28","doi-asserted-by":"publisher","first-page":"30317","DOI":"10.18632\/oncotarget.4505","volume":"6","author":"L Wang","year":"2015","unstructured":"Wang L, et al. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK\/T cell lymphoma in the era of asparaginase. Oncotarget. 2015;6(30):30317\u201326.","journal-title":"Oncotarget"},{"issue":"2","key":"900_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/PPO.0000000000000581","volume":"28","author":"SS He","year":"2022","unstructured":"He SS, et al. Circulating plasma Epstein-Barr Virus DNA load during the follow-up periods predicts recurrence and metastasis in Nasopharyngeal Carcinoma. Cancer J. 2022;28(2):85\u201392.","journal-title":"Cancer J"},{"issue":"1","key":"900_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13027-021-00353-8","volume":"16","author":"A Gihbid","year":"2021","unstructured":"Gihbid A, et al. Circulating cell-free epstein-barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer. 2021;16(1):15.","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"900_CR31","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.3892\/ol.2015.3628","volume":"10","author":"FP Zhao","year":"2015","unstructured":"Zhao FP, et al. Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma. Oncol Lett. 2015;10(5):2888\u201394.","journal-title":"Oncol Lett"},{"issue":"6","key":"900_CR32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cmi.2015.02.017","volume":"21","author":"JH Liang","year":"2015","unstructured":"Liang JH, et al. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma. Clin Microbiol Infect. 2015;21(6):596\u2013602.","journal-title":"Clin Microbiol Infect"},{"key":"900_CR33","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1016\/j.clml.2016.02.014","volume":"16","author":"BM Haverkos","year":"2016","unstructured":"Haverkos BM, et al. Increased levels of plasma Epstein Barr Virus DNA identify a poor-risk subset of patients with advanced stage cutaneous T-cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2016;16:S181\u201390.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"900_CR34","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/cancers13081785","volume":"13","author":"J Hwang","year":"2021","unstructured":"Hwang J, Suh CH, Won Kim K, Kim HS, Armand P, Huang RY, Guenette JP. The incidence of Epstein-Barr Virus-positive diffuse large B-Cell Lymphoma: A systematic review and meta-analysis. Cancers. 2021;13(8):1785.","journal-title":"Cancers"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00900-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00900-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00900-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:26:53Z","timestamp":1789475213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00900-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00900-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\"The original online version of this article was revised: due to incorrect footnote in the article\".","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}